Benzodiazepine Taper in an Older Adult on Chronic Opioids
Mrs. B is a 74-year-old woman with osteoarthritis, mild cognitive impairment (MoCA 23/30), and two falls in 6 months. She takes oxycodone 10 mg every 6 hours and alprazolam 1 mg three times daily, both for over a decade. Her daughter notices she sometimes takes an extra alprazolam when anxious and has been more confused. The patient wants to stop alprazolam but fears withdrawal. Her PCP is reluctant to taper because of anxiety. PDMP shows no other prescribers. She lives alone; daughter visits daily. She has no history of seizures or alcohol use.
1. How would you distinguish a sedative-hypnotic use disorder from expected physiologic dependence in this patient?
Read the worked answer
Physiologic dependence (tolerance and withdrawal) is expected after years of daily alprazolam and is not itself a DSM-5 use disorder. A use disorder requires a maladaptive pattern: taking more than prescribed, craving, unsuccessful efforts to cut down, continued use despite cognitive impairment and falls, and use causing social or functional problems. Her daughter's report of extra doses and the falls and cognitive decline are relevant, but I need to quantify how often, why, and whether she is escalating. Review the PDMP, pill counts, and pharmacy records.
The differential includes an anxiety disorder, depression, insomnia, pain, opioid effects, alcohol use, delirium, and a neurodegenerative disorder. Her MoCA of 23 may be worsened by the combination of alprazolam and oxycodone; reassess cognition after a gradual taper. Collateral information and a nonjudgmental interview are essential. Do not label her as 'addicted' without meeting criteria.
2. Outline a safe taper and monitoring plan, including the opioid co-prescription.
Read the worked answer
Do not stop alprazolam abruptly. Taper slowly, about 5-10% every two to four weeks, with slower steps near the end; in older adults, expect a longer taper. A common strategy is to reduce the total daily dose by 0.25 mg every two to four weeks, adjusting for withdrawal. Switching to a longer-acting benzodiazepine can smooth withdrawal but in older adults risks accumulation and falls; if used, use low-dose clonazepam or diazepam with careful monitoring and only by an experienced clinician. Provide CBT for anxiety and insomnia, sleep hygiene, and relaxation; treat pain with nonopioid modalities.
Monitor for withdrawal (anxiety, tremor, insomnia, perceptual changes, seizures), confusion, falls, and respiratory depression. The oxycodone-alprazolam combination carries a boxed warning; offer naloxone, counsel the daughter, and consider a separate slow opioid taper after the benzodiazepine is stabilized. Coordinate with a single prescriber and the pharmacy. If severe withdrawal or seizures occur, arrange urgent medical care.
3. What systems and caregiver issues need to be addressed for this taper to succeed?
Read the worked answer
Use a single prescriber and pharmacy, check the PDMP, and document the taper plan. Involve the daughter with the patient's permission, including how to give and store medications and what to do in an emergency. Assess home safety and fall risk; consider physical therapy and a home safety evaluation. Arrange transportation or telehealth if visits are burdensome. Educate about withdrawal and the reason for slow tapering.
Avoid an involuntary rapid discontinuation, which risks seizures and fractures. Coordinate with geriatrics, psychiatry, and primary care, and use a shared decision-making framework. If cognitive impairment worsens, reconsider the differential rather than assuming medication effect. Provide written instructions and a follow-up appointment within two to four weeks. The goal is harm reduction and improved function, not simply a zero dose.